Table 4.
Groups | Before treatment/3 months after treatment | CD3+(%) | CD8+(%) | CD4+(%) | CD4/CD8 | NK cell(%) | Total B cell(%) |
---|---|---|---|---|---|---|---|
C group (25 cases) | NA | 66.14±6.34 | 24.16±2.19 | 39.45±3.65 | 1.63±0.24 | 11.82±2.43 | 21.77±2.48 |
A group (44 cases) | Before treatment | 66.53±6.12 | 26.41±3.871 | 35.73±3.641 | 1.47±0.431 | 6.74±1.591 | 24.85±3.12 |
3 months of treatment | 71.65±6.841,2 | 26.84±3.411 | 37.49±4.21 | 1.46±0.281 | 12.35±1.892 | 14.64±1.781,2 | |
B group(43 cases) | Before treatment | 67.68±6.71 | 26.68±2.541 | 35.47±3.831 | 1.38±0.251 | 7.25±1.281 | 23.82±2.46 |
3 months of treatment | 66.13±6.243 | 27.25±2.711 | 32.42±3.293 | 1.26±0.243 | 10.65±1.952,3 | 20.96±2.742,3 |
Note: 1. Compared with the control group, P < 0.05; 2. Compared with the group before treatment, P< 0.05; 3. Compared with A group, P < 0.05. CD=cluster of differentiation; NK cell=Natural killer cell; NA=Not applicable.